A Phase-1/2 Study of Adenovirus-P53 Transduced Dendritic Cell Vaccine in Combination With Indoximod in Metastatic Solid Tumors and Invasive Breast Cancer
Oncotarget - United States
doi 10.18632/oncotarget.24118
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 10, 2018
Authors
Publisher
Impact Journals, LLC